Empowering Healthcare Decisions
Right at the point of Care

Diabetic retinopathy (DR) is often underdiagnosed, leading to partial and irreversible blindness in some patients. Dr Ida Ilyani Adam, Consultant Endocrinologist, and Dr Malisa Ami, Consultant Ophthalmologist, discuss the challenges surrounding DR management, share their perspectives on how such oversights can be avoided and present a case study where co-management led to improved outcomes for the patient.

At the recent European Congress on Obesity (ECO) 2026, held in Istanbul, Türkiye, researchers presented the results of a new post-hoc analysis of the STEP UP trial. The analysis revealed that a subset of patients in the semaglutide 2.4 mg arm experienced significant weight loss of almost 25%.

Osteoporosis (or porous bones) is a progressive condition in which bones become structurally weak and are more likely to fracture or break. Menopause is the most common cause of primary osteoporosis in women. Estrogen helps prevent bones from getting weaker by slowing the natural breakdown of bone, its reduction during menopause significantly speeds up bone loss. The rapid phase of bone loss occurs in a 3-year period around the final menstrual period (FMP); bone mineral density (BMD) begins to decline around 1 year prior to the FMP, and continues to decrease in early post menopause, with a slight reduction in loss rate around 2 years after the FMP. During the 3-year-long rapid bone loss phase in the transmenopause, the average rate of decline in BMD among White women was 2.5% per year in the lumbar spine and 1.8% per year in the femoral neck.